Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most
common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal …

Purpose Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with
rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). MYC …

The International Human Genome Sequencing Consortium (IHGSC) used a hierarchical
mapping and sequencing strategy to construct the working draft of the human genome. This …

Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous cancer composed of
at least 2 molecular subtypes that differ in gene expression and distribution of mutations. …

Mantle cell lymphoma (MCL), an aggressive subtype of non-Hodgkin lymphoma, is characterized
by the hallmark translocation t(11;14)(q13;q32) and the resulting overexpression of …

We present an independent comparative analysis of seven recently developed gene-finding
programs: FGENES , GeneMark.hmm , Genie , Genscan , HMMgene , Morgan , and MZEF . …

Classical Hodgkin lymphoma and primary mediastinal B cell lymphoma (PMBCL) are
related lymphomas sharing pathological, molecular and clinical characteristics. Here we …

The human genome is by far the largest genome to be sequenced, and its size and complexity
present many challenges for sequence assembly. The International Human Genome …

Purpose Our aim was to reliably identify patients with advanced-stage classical Hodgkin
lymphoma (cHL) at increased risk of death by developing a robust predictor of overall survival (…

We have recently reported the application of RNAseq to mantle cell lymphoma (MCL)
transcriptomes revealing recurrent mutations in NOTCH1. Here we describe the targeted …